Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs
Introduction The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick...
Gespeichert in:
Veröffentlicht in: | Drug and alcohol review 2022-03, Vol.41 (3), p.697-705 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 705 |
---|---|
container_issue | 3 |
container_start_page | 697 |
container_title | Drug and alcohol review |
container_volume | 41 |
creator | Le, Sao M. Trouiller, Philippe Duong, Thi H. Khuat, Thi H. O. Pham, Minh K. Vallo, Roselyne Rapoud, Delphine Quillet, Catherine Nguyen, Thuy L. Nguyen, Quang D. Nham, Thi Tuyet T. Hoang, Thi G. Feelemyer, Jonathan Vu, Hai V. Moles, Jean‐Pierre Doan, Hong Q. Laureillard, Didier Des Jarlais, Don C. Nagot, Nicolas Michel, Laurent |
description | Introduction
The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick screening tool (QST) that community‐based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs (PWID), in order to refer them appropriately to mental health specialists.
Methods
We devised a tool that included nine questions covering anxiety, depression, suicide risk and psychotic symptomatology. Its use required no specific background and 2 h training. Specificity and sensitivity of the QST were assessed in a population of 418 PWID recruited via respondent driven sampling, using the Mini International Neuropsychiatric Interview questionnaire plus clinical evaluation as a reference standard. Acceptability was assessed using a self‐administered anonymous questionnaire submitted to all CBO members who used the QST.
Results
CBO members considered the QST easy to use, relevant and helpful to deal with mental health issues. Area under the curve for detection of any symptom using the QST was 0.770. The maximum sensitivity and specificity were reached with a cut‐off of 2 [sensitivity was 71.1% (95% confidence interval 62.4, 78.8), specificity was 75.9% (70.5, 80.7)].
Discussion and Conclusions
The QST appeared to be both efficient and well accepted. Given the burden of mental health problems among hard‐to‐reach PWID in developing countries, community‐based screenings such as this one could be a particularly appropriate response. |
doi_str_mv | 10.1111/dar.13402 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10150937</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2638869129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4782-657e5e9faf7afd55caea68081cd6e9b07b5d0b2c0ce8da74df6bbfbd5a7ab94d3</originalsourceid><addsrcrecordid>eNp1kcFu1DAURS1ERYfCgh9AllixSGsnsZOs0KgFijRSpQrW1rP9MskoiYOdTDWs-IR-Y78ET6cUqIQ3lu3j42tdQt5wdsrjOLPgT3mWs_QZWfBciiTLZPqcLFglqkSkmTwmL0PYMMZSIdIX5DjLi1IWQizIjwvcYufGHoeJwmAphIAh3C9dTYEa1_fz0E67u5-3GgJaGoxHHNphTSfnOlo7T_c4dLRB6KaG2jY4b9EHCr2L2Ihu7JDeNI62wwbNRK2f1-EVOaqhC_j6YT4h3z59_Hp-mayuPn85X64SE1OmiRQFCqxqqAuorRAGEGTJSm6sxEqzQgvLdGqYwdJCkdtaal1rK6AAXeU2OyEfDt5x1j1aE7N66NTo2x78Tjlo1b8nQ9uotdsqzrhgVVZEw_uDoXly73K5Uvs9lsmcCSa2PLLvHl7z7vuMYVIbN_shflClMitLWfG0-mM03oXgsX7Ucqb2narYqbrvNLJv_87_SP4uMQJnB-Cm7XD3f5O6WF4flL8AytWwJA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638869129</pqid></control><display><type>article</type><title>Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Sociological Abstracts</source><creator>Le, Sao M. ; Trouiller, Philippe ; Duong, Thi H. ; Khuat, Thi H. O. ; Pham, Minh K. ; Vallo, Roselyne ; Rapoud, Delphine ; Quillet, Catherine ; Nguyen, Thuy L. ; Nguyen, Quang D. ; Nham, Thi Tuyet T. ; Hoang, Thi G. ; Feelemyer, Jonathan ; Vu, Hai V. ; Moles, Jean‐Pierre ; Doan, Hong Q. ; Laureillard, Didier ; Des Jarlais, Don C. ; Nagot, Nicolas ; Michel, Laurent</creator><creatorcontrib>Le, Sao M. ; Trouiller, Philippe ; Duong, Thi H. ; Khuat, Thi H. O. ; Pham, Minh K. ; Vallo, Roselyne ; Rapoud, Delphine ; Quillet, Catherine ; Nguyen, Thuy L. ; Nguyen, Quang D. ; Nham, Thi Tuyet T. ; Hoang, Thi G. ; Feelemyer, Jonathan ; Vu, Hai V. ; Moles, Jean‐Pierre ; Doan, Hong Q. ; Laureillard, Didier ; Des Jarlais, Don C. ; Nagot, Nicolas ; Michel, Laurent ; DRIVE Study Team ; for the DRIVE Study Team</creatorcontrib><description>Introduction
The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick screening tool (QST) that community‐based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs (PWID), in order to refer them appropriately to mental health specialists.
Methods
We devised a tool that included nine questions covering anxiety, depression, suicide risk and psychotic symptomatology. Its use required no specific background and 2 h training. Specificity and sensitivity of the QST were assessed in a population of 418 PWID recruited via respondent driven sampling, using the Mini International Neuropsychiatric Interview questionnaire plus clinical evaluation as a reference standard. Acceptability was assessed using a self‐administered anonymous questionnaire submitted to all CBO members who used the QST.
Results
CBO members considered the QST easy to use, relevant and helpful to deal with mental health issues. Area under the curve for detection of any symptom using the QST was 0.770. The maximum sensitivity and specificity were reached with a cut‐off of 2 [sensitivity was 71.1% (95% confidence interval 62.4, 78.8), specificity was 75.9% (70.5, 80.7)].
Discussion and Conclusions
The QST appeared to be both efficient and well accepted. Given the burden of mental health problems among hard‐to‐reach PWID in developing countries, community‐based screenings such as this one could be a particularly appropriate response.</description><identifier>ISSN: 0959-5236</identifier><identifier>EISSN: 1465-3362</identifier><identifier>DOI: 10.1111/dar.13402</identifier><identifier>PMID: 34786755</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>Clinical assessment ; Community ; community setting ; Developing countries ; Drug Users ; Drugs ; Health problems ; Human health and pathology ; Humans ; LDCs ; Life Sciences ; Mass Screening ; Medical screening ; Mental depression ; Mental Disorders ; Mental Disorders - diagnosis ; Mental Disorders - epidemiology ; Mental Disorders - psychology ; Mental Health ; Mental health care ; Mental health services ; people who inject drugs ; Prevalence ; Psychological assessment ; Psychosis ; Questionnaires ; screening test ; Sensitivity training ; Specialists ; Substance Abuse, Intravenous ; Substance Abuse, Intravenous - epidemiology ; Substance Abuse, Intravenous - psychology ; Suicide ; Tests</subject><ispartof>Drug and alcohol review, 2022-03, Vol.41 (3), p.697-705</ispartof><rights>2021 Australasian Professional Society on Alcohol and other Drugs.</rights><rights>2022 Australasian Professional Society on Alcohol and other Drugs (APSAD)</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4782-657e5e9faf7afd55caea68081cd6e9b07b5d0b2c0ce8da74df6bbfbd5a7ab94d3</citedby><cites>FETCH-LOGICAL-c4782-657e5e9faf7afd55caea68081cd6e9b07b5d0b2c0ce8da74df6bbfbd5a7ab94d3</cites><orcidid>0000-0002-4068-8351 ; 0000-0001-6617-4992 ; 0000-0003-2974-3484 ; 0000-0002-2000-7838 ; 0000-0002-0104-9047 ; 0000-0002-2447-6754 ; 0000-0002-0157-8168 ; 0000-0002-6863-6350 ; 0000-0002-3493-2821</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdar.13402$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdar.13402$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,30976,33751,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34786755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.umontpellier.fr/hal-03640505$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Le, Sao M.</creatorcontrib><creatorcontrib>Trouiller, Philippe</creatorcontrib><creatorcontrib>Duong, Thi H.</creatorcontrib><creatorcontrib>Khuat, Thi H. O.</creatorcontrib><creatorcontrib>Pham, Minh K.</creatorcontrib><creatorcontrib>Vallo, Roselyne</creatorcontrib><creatorcontrib>Rapoud, Delphine</creatorcontrib><creatorcontrib>Quillet, Catherine</creatorcontrib><creatorcontrib>Nguyen, Thuy L.</creatorcontrib><creatorcontrib>Nguyen, Quang D.</creatorcontrib><creatorcontrib>Nham, Thi Tuyet T.</creatorcontrib><creatorcontrib>Hoang, Thi G.</creatorcontrib><creatorcontrib>Feelemyer, Jonathan</creatorcontrib><creatorcontrib>Vu, Hai V.</creatorcontrib><creatorcontrib>Moles, Jean‐Pierre</creatorcontrib><creatorcontrib>Doan, Hong Q.</creatorcontrib><creatorcontrib>Laureillard, Didier</creatorcontrib><creatorcontrib>Des Jarlais, Don C.</creatorcontrib><creatorcontrib>Nagot, Nicolas</creatorcontrib><creatorcontrib>Michel, Laurent</creatorcontrib><creatorcontrib>DRIVE Study Team</creatorcontrib><creatorcontrib>for the DRIVE Study Team</creatorcontrib><title>Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs</title><title>Drug and alcohol review</title><addtitle>Drug Alcohol Rev</addtitle><description>Introduction
The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick screening tool (QST) that community‐based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs (PWID), in order to refer them appropriately to mental health specialists.
Methods
We devised a tool that included nine questions covering anxiety, depression, suicide risk and psychotic symptomatology. Its use required no specific background and 2 h training. Specificity and sensitivity of the QST were assessed in a population of 418 PWID recruited via respondent driven sampling, using the Mini International Neuropsychiatric Interview questionnaire plus clinical evaluation as a reference standard. Acceptability was assessed using a self‐administered anonymous questionnaire submitted to all CBO members who used the QST.
Results
CBO members considered the QST easy to use, relevant and helpful to deal with mental health issues. Area under the curve for detection of any symptom using the QST was 0.770. The maximum sensitivity and specificity were reached with a cut‐off of 2 [sensitivity was 71.1% (95% confidence interval 62.4, 78.8), specificity was 75.9% (70.5, 80.7)].
Discussion and Conclusions
The QST appeared to be both efficient and well accepted. Given the burden of mental health problems among hard‐to‐reach PWID in developing countries, community‐based screenings such as this one could be a particularly appropriate response.</description><subject>Clinical assessment</subject><subject>Community</subject><subject>community setting</subject><subject>Developing countries</subject><subject>Drug Users</subject><subject>Drugs</subject><subject>Health problems</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>LDCs</subject><subject>Life Sciences</subject><subject>Mass Screening</subject><subject>Medical screening</subject><subject>Mental depression</subject><subject>Mental Disorders</subject><subject>Mental Disorders - diagnosis</subject><subject>Mental Disorders - epidemiology</subject><subject>Mental Disorders - psychology</subject><subject>Mental Health</subject><subject>Mental health care</subject><subject>Mental health services</subject><subject>people who inject drugs</subject><subject>Prevalence</subject><subject>Psychological assessment</subject><subject>Psychosis</subject><subject>Questionnaires</subject><subject>screening test</subject><subject>Sensitivity training</subject><subject>Specialists</subject><subject>Substance Abuse, Intravenous</subject><subject>Substance Abuse, Intravenous - epidemiology</subject><subject>Substance Abuse, Intravenous - psychology</subject><subject>Suicide</subject><subject>Tests</subject><issn>0959-5236</issn><issn>1465-3362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>BHHNA</sourceid><recordid>eNp1kcFu1DAURS1ERYfCgh9AllixSGsnsZOs0KgFijRSpQrW1rP9MskoiYOdTDWs-IR-Y78ET6cUqIQ3lu3j42tdQt5wdsrjOLPgT3mWs_QZWfBciiTLZPqcLFglqkSkmTwmL0PYMMZSIdIX5DjLi1IWQizIjwvcYufGHoeJwmAphIAh3C9dTYEa1_fz0E67u5-3GgJaGoxHHNphTSfnOlo7T_c4dLRB6KaG2jY4b9EHCr2L2Ihu7JDeNI62wwbNRK2f1-EVOaqhC_j6YT4h3z59_Hp-mayuPn85X64SE1OmiRQFCqxqqAuorRAGEGTJSm6sxEqzQgvLdGqYwdJCkdtaal1rK6AAXeU2OyEfDt5x1j1aE7N66NTo2x78Tjlo1b8nQ9uotdsqzrhgVVZEw_uDoXly73K5Uvs9lsmcCSa2PLLvHl7z7vuMYVIbN_shflClMitLWfG0-mM03oXgsX7Ucqb2narYqbrvNLJv_87_SP4uMQJnB-Cm7XD3f5O6WF4flL8AytWwJA</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Le, Sao M.</creator><creator>Trouiller, Philippe</creator><creator>Duong, Thi H.</creator><creator>Khuat, Thi H. O.</creator><creator>Pham, Minh K.</creator><creator>Vallo, Roselyne</creator><creator>Rapoud, Delphine</creator><creator>Quillet, Catherine</creator><creator>Nguyen, Thuy L.</creator><creator>Nguyen, Quang D.</creator><creator>Nham, Thi Tuyet T.</creator><creator>Hoang, Thi G.</creator><creator>Feelemyer, Jonathan</creator><creator>Vu, Hai V.</creator><creator>Moles, Jean‐Pierre</creator><creator>Doan, Hong Q.</creator><creator>Laureillard, Didier</creator><creator>Des Jarlais, Don C.</creator><creator>Nagot, Nicolas</creator><creator>Michel, Laurent</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7U3</scope><scope>BHHNA</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4068-8351</orcidid><orcidid>https://orcid.org/0000-0001-6617-4992</orcidid><orcidid>https://orcid.org/0000-0003-2974-3484</orcidid><orcidid>https://orcid.org/0000-0002-2000-7838</orcidid><orcidid>https://orcid.org/0000-0002-0104-9047</orcidid><orcidid>https://orcid.org/0000-0002-2447-6754</orcidid><orcidid>https://orcid.org/0000-0002-0157-8168</orcidid><orcidid>https://orcid.org/0000-0002-6863-6350</orcidid><orcidid>https://orcid.org/0000-0002-3493-2821</orcidid></search><sort><creationdate>202203</creationdate><title>Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs</title><author>Le, Sao M. ; Trouiller, Philippe ; Duong, Thi H. ; Khuat, Thi H. O. ; Pham, Minh K. ; Vallo, Roselyne ; Rapoud, Delphine ; Quillet, Catherine ; Nguyen, Thuy L. ; Nguyen, Quang D. ; Nham, Thi Tuyet T. ; Hoang, Thi G. ; Feelemyer, Jonathan ; Vu, Hai V. ; Moles, Jean‐Pierre ; Doan, Hong Q. ; Laureillard, Didier ; Des Jarlais, Don C. ; Nagot, Nicolas ; Michel, Laurent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4782-657e5e9faf7afd55caea68081cd6e9b07b5d0b2c0ce8da74df6bbfbd5a7ab94d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Clinical assessment</topic><topic>Community</topic><topic>community setting</topic><topic>Developing countries</topic><topic>Drug Users</topic><topic>Drugs</topic><topic>Health problems</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>LDCs</topic><topic>Life Sciences</topic><topic>Mass Screening</topic><topic>Medical screening</topic><topic>Mental depression</topic><topic>Mental Disorders</topic><topic>Mental Disorders - diagnosis</topic><topic>Mental Disorders - epidemiology</topic><topic>Mental Disorders - psychology</topic><topic>Mental Health</topic><topic>Mental health care</topic><topic>Mental health services</topic><topic>people who inject drugs</topic><topic>Prevalence</topic><topic>Psychological assessment</topic><topic>Psychosis</topic><topic>Questionnaires</topic><topic>screening test</topic><topic>Sensitivity training</topic><topic>Specialists</topic><topic>Substance Abuse, Intravenous</topic><topic>Substance Abuse, Intravenous - epidemiology</topic><topic>Substance Abuse, Intravenous - psychology</topic><topic>Suicide</topic><topic>Tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le, Sao M.</creatorcontrib><creatorcontrib>Trouiller, Philippe</creatorcontrib><creatorcontrib>Duong, Thi H.</creatorcontrib><creatorcontrib>Khuat, Thi H. O.</creatorcontrib><creatorcontrib>Pham, Minh K.</creatorcontrib><creatorcontrib>Vallo, Roselyne</creatorcontrib><creatorcontrib>Rapoud, Delphine</creatorcontrib><creatorcontrib>Quillet, Catherine</creatorcontrib><creatorcontrib>Nguyen, Thuy L.</creatorcontrib><creatorcontrib>Nguyen, Quang D.</creatorcontrib><creatorcontrib>Nham, Thi Tuyet T.</creatorcontrib><creatorcontrib>Hoang, Thi G.</creatorcontrib><creatorcontrib>Feelemyer, Jonathan</creatorcontrib><creatorcontrib>Vu, Hai V.</creatorcontrib><creatorcontrib>Moles, Jean‐Pierre</creatorcontrib><creatorcontrib>Doan, Hong Q.</creatorcontrib><creatorcontrib>Laureillard, Didier</creatorcontrib><creatorcontrib>Des Jarlais, Don C.</creatorcontrib><creatorcontrib>Nagot, Nicolas</creatorcontrib><creatorcontrib>Michel, Laurent</creatorcontrib><creatorcontrib>DRIVE Study Team</creatorcontrib><creatorcontrib>for the DRIVE Study Team</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Social Services Abstracts</collection><collection>Sociological Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Drug and alcohol review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le, Sao M.</au><au>Trouiller, Philippe</au><au>Duong, Thi H.</au><au>Khuat, Thi H. O.</au><au>Pham, Minh K.</au><au>Vallo, Roselyne</au><au>Rapoud, Delphine</au><au>Quillet, Catherine</au><au>Nguyen, Thuy L.</au><au>Nguyen, Quang D.</au><au>Nham, Thi Tuyet T.</au><au>Hoang, Thi G.</au><au>Feelemyer, Jonathan</au><au>Vu, Hai V.</au><au>Moles, Jean‐Pierre</au><au>Doan, Hong Q.</au><au>Laureillard, Didier</au><au>Des Jarlais, Don C.</au><au>Nagot, Nicolas</au><au>Michel, Laurent</au><aucorp>DRIVE Study Team</aucorp><aucorp>for the DRIVE Study Team</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs</atitle><jtitle>Drug and alcohol review</jtitle><addtitle>Drug Alcohol Rev</addtitle><date>2022-03</date><risdate>2022</risdate><volume>41</volume><issue>3</issue><spage>697</spage><epage>705</epage><pages>697-705</pages><issn>0959-5236</issn><eissn>1465-3362</eissn><abstract>Introduction
The prevalence of mental health disorders among people who use drugs is high and well documented. This hard‐to‐reach population faces a very low awareness and access to mental health care, especially in developing countries. The objectives of this study were to design and assess a quick screening tool (QST) that community‐based organisations (CBO) could routinely apply to a Vietnamese population of people who inject drugs (PWID), in order to refer them appropriately to mental health specialists.
Methods
We devised a tool that included nine questions covering anxiety, depression, suicide risk and psychotic symptomatology. Its use required no specific background and 2 h training. Specificity and sensitivity of the QST were assessed in a population of 418 PWID recruited via respondent driven sampling, using the Mini International Neuropsychiatric Interview questionnaire plus clinical evaluation as a reference standard. Acceptability was assessed using a self‐administered anonymous questionnaire submitted to all CBO members who used the QST.
Results
CBO members considered the QST easy to use, relevant and helpful to deal with mental health issues. Area under the curve for detection of any symptom using the QST was 0.770. The maximum sensitivity and specificity were reached with a cut‐off of 2 [sensitivity was 71.1% (95% confidence interval 62.4, 78.8), specificity was 75.9% (70.5, 80.7)].
Discussion and Conclusions
The QST appeared to be both efficient and well accepted. Given the burden of mental health problems among hard‐to‐reach PWID in developing countries, community‐based screenings such as this one could be a particularly appropriate response.</abstract><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>34786755</pmid><doi>10.1111/dar.13402</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-4068-8351</orcidid><orcidid>https://orcid.org/0000-0001-6617-4992</orcidid><orcidid>https://orcid.org/0000-0003-2974-3484</orcidid><orcidid>https://orcid.org/0000-0002-2000-7838</orcidid><orcidid>https://orcid.org/0000-0002-0104-9047</orcidid><orcidid>https://orcid.org/0000-0002-2447-6754</orcidid><orcidid>https://orcid.org/0000-0002-0157-8168</orcidid><orcidid>https://orcid.org/0000-0002-6863-6350</orcidid><orcidid>https://orcid.org/0000-0002-3493-2821</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-5236 |
ispartof | Drug and alcohol review, 2022-03, Vol.41 (3), p.697-705 |
issn | 0959-5236 1465-3362 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10150937 |
source | Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Wiley Online Library Journals Frontfile Complete; Sociological Abstracts |
subjects | Clinical assessment Community community setting Developing countries Drug Users Drugs Health problems Human health and pathology Humans LDCs Life Sciences Mass Screening Medical screening Mental depression Mental Disorders Mental Disorders - diagnosis Mental Disorders - epidemiology Mental Disorders - psychology Mental Health Mental health care Mental health services people who inject drugs Prevalence Psychological assessment Psychosis Questionnaires screening test Sensitivity training Specialists Substance Abuse, Intravenous Substance Abuse, Intravenous - epidemiology Substance Abuse, Intravenous - psychology Suicide Tests |
title | Development and assessment of a community‐based screening tool for mental health disorders among people who inject drugs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T10%3A06%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20assessment%20of%20a%20community%E2%80%90based%20screening%20tool%20for%20mental%20health%20disorders%20among%20people%20who%20inject%20drugs&rft.jtitle=Drug%20and%20alcohol%20review&rft.au=Le,%20Sao%20M.&rft.aucorp=DRIVE%20Study%20Team&rft.date=2022-03&rft.volume=41&rft.issue=3&rft.spage=697&rft.epage=705&rft.pages=697-705&rft.issn=0959-5236&rft.eissn=1465-3362&rft_id=info:doi/10.1111/dar.13402&rft_dat=%3Cproquest_pubme%3E2638869129%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638869129&rft_id=info:pmid/34786755&rfr_iscdi=true |